Nanlan Luo

2.2k total citations · 1 hit paper
16 papers, 1.9k citations indexed

About

Nanlan Luo is a scholar working on Epidemiology, Physiology and Molecular Biology. According to data from OpenAlex, Nanlan Luo has authored 16 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 8 papers in Physiology and 7 papers in Molecular Biology. Recurrent topics in Nanlan Luo's work include Adipokines, Inflammation, and Metabolic Diseases (9 papers), Adipose Tissue and Metabolism (8 papers) and Peroxisome Proliferator-Activated Receptors (4 papers). Nanlan Luo is often cited by papers focused on Adipokines, Inflammation, and Metabolic Diseases (9 papers), Adipose Tissue and Metabolism (8 papers) and Peroxisome Proliferator-Activated Receptors (4 papers). Nanlan Luo collaborates with scholars based in United States and China. Nanlan Luo's co-authors include Yuchang Fu, Richard L. Klein, W. Timothy Garvey, W. Timothy Garvey, Maria F. Lopes‐Virella, Penny Wallace, Cristina Lara‐Castro, B H Chung, Ling Tian and Xiaolin Zhu and has published in prestigious journals such as Journal of Biological Chemistry, Diabetes and Biochemical and Biophysical Research Communications.

In The Last Decade

Nanlan Luo

16 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Adiponectin promotes adipocyte differentiation, insulin sensitivity, and lipid accumulation

2005 539 citations Yuchang Fu, Nanlan Luo et al. Journal of Lipid Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nanlan Luo United States	14	1.1k	781	626	332	254	16	1.9k
Miki Okada‐Iwabu Japan	18	921 0.9×	731 0.9×	649 1.0×	240 0.7×	159 0.6×	29	1.8k
Yusuke Hada Japan	8	1.4k 1.3×	883 1.1×	428 0.7×	294 0.9×	213 0.8×	8	1.7k
Todd Schraw United States	13	1.3k 1.2×	1.2k 1.5×	650 1.0×	387 1.2×	236 0.9×	16	2.4k
Markus Clemenz Germany	14	733 0.7×	606 0.8×	601 1.0×	364 1.1×	304 1.2×	15	1.7k
Yingfeng Deng United States	26	811 0.8×	769 1.0×	1.1k 1.8×	268 0.8×	211 0.8×	43	2.5k
Yuexing Yuan China	25	985 0.9×	752 1.0×	764 1.2×	751 2.3×	183 0.7×	44	2.5k
Aiwei Yao‐Borengasser United States	23	1.3k 1.2×	1.3k 1.7×	1.2k 1.9×	384 1.2×	316 1.2×	32	3.0k
Kae Won Cho United States	27	817 0.8×	732 0.9×	684 1.1×	176 0.5×	520 2.0×	54	2.2k
Maziyar Saberi United States	13	887 0.8×	967 1.2×	801 1.3×	179 0.5×	284 1.1×	14	2.1k
Eva Klimčáková France	27	898 0.8×	1.3k 1.6×	645 1.0×	392 1.2×	88 0.3×	37	2.1k

Countries citing papers authored by Nanlan Luo

Since Specialization

Citations

This map shows the geographic impact of Nanlan Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nanlan Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nanlan Luo more than expected).

Fields of papers citing papers by Nanlan Luo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nanlan Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nanlan Luo. The network helps show where Nanlan Luo may publish in the future.

Co-authorship network of co-authors of Nanlan Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Nanlan Luo. A scholar is included among the top collaborators of Nanlan Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nanlan Luo. Nanlan Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Zhang, Wei, Mengrui Wu, Teayoun Kim, et al.. (2016). Skeletal Muscle TRIB3 Mediates Glucose Toxicity in Diabetes and High- Fat Diet–Induced Insulin Resistance. Diabetes. 65(8). 2380–2391. 35 indexed citations

Luo, Nanlan, B H Chung, Xiangdong Wang, et al.. (2013). Enhanced adiponectin actions by overexpression of adiponectin receptor 1 in macrophages. Atherosclerosis. 228(1). 124–135. 41 indexed citations

Luo, Nanlan, Xiangdong Wang, Wei Zhang, W. Timothy Garvey, & Yuchang Fu. (2013). AdR1-TG/TALLYHO mice have improved lipid accumulation and insulin sensitivity. Biochemical and Biophysical Research Communications. 433(4). 567–572. 2 indexed citations

Zhu, Xiaolin, Raquel M. Walton, Ling Tian, et al.. (2012). Prostaglandin A2 Enhances Cellular Insulin Sensitivity via a Mechanism that Involves the Orphan Nuclear Receptor NR4A3. Hormone and Metabolic Research. 45(3). 213–220. 11 indexed citations

Tian, Ling, et al.. (2011). Adiponectin-AdipoR1/2-APPL1 signaling axis suppresses human foam cell formation: Differential ability of AdipoR1 and AdipoR2 to regulate inflammatory cytokine responses. Atherosclerosis. 221(1). 66–75. 78 indexed citations

Luo, Nanlan, Xiangdong Wang, B H Chung, et al.. (2011). Effects of macrophage-specific adiponectin expression on lipid metabolism in vivo. American Journal of Physiology-Endocrinology and Metabolism. 301(1). E180–E186. 21 indexed citations

Luo, Nanlan, Jian Liu, B H Chung, et al.. (2010). Macrophage Adiponectin Expression Improves Insulin Sensitivity and Protects Against Inflammation and Atherosclerosis. Diabetes. 59(4). 791–799. 94 indexed citations

Tian, Ling, Nanlan Luo, Richard L. Klein, et al.. (2008). Adiponectin reduces lipid accumulation in macrophage foam cells. Atherosclerosis. 202(1). 152–161. 114 indexed citations

Fu, Yuchang, et al.. (2007). NR4A Orphan Nuclear Receptors Modulate Insulin Action and the Glucose Transport System. Journal of Biological Chemistry. 282(43). 31525–31533. 107 indexed citations

10.

Fu, Yuchang, et al.. (2006). Proinflammatory cytokine production and insulin sensitivity regulated by overexpression of resistin in 3T3-L1 adipocytes. Nutrition & Metabolism. 3(1). 28–28. 44 indexed citations

11.

Lara‐Castro, Cristina, Nanlan Luo, Penny Wallace, Richard L. Klein, & W. Timothy Garvey. (2006). Adiponectin Multimeric Complexes and the Metabolic Syndrome Trait Cluster. Diabetes. 55(1). 249–259. 399 indexed citations

12.

Fu, Yuchang, Nanlan Luo, Richard L. Klein, & W. Timothy Garvey. (2005). Adiponectin promotes adipocyte differentiation, insulin sensitivity, and lipid accumulation. Journal of Lipid Research. 46(7). 1369–1379. 539 indexed citations breakdown →

13.

Fu, Yuchang, et al.. (2005). Lipid metabolism mediated by adipocyte lipid binding protein (ALBP/aP2) gene expression in human THP-1 macrophages. Atherosclerosis. 188(1). 102–111. 62 indexed citations

14.

Fu, Yuchang, Nanlan Luo, & Maria F. Lopes‐Virella. (2002). Upregulation of interleukin-8 expression by prostaglandin D2 metabolite 15-deoxy-delta12, 14 prostaglandin J2 (15d-PGJ2) in human THP-1 macrophages. Atherosclerosis. 160(1). 11–20. 41 indexed citations

15.

Fu, Yuchang, Nanlan Luo, Maria F. Lopes‐Virella, & W. Timothy Garvey. (2002). The adipocyte lipid binding protein (ALBP/aP2) gene facilitates foam cell formation in human THP-1 macrophages. Atherosclerosis. 165(2). 259–269. 154 indexed citations

16.

Fu, Yuchang, Nanlan Luo, & Maria F. Lopes‐Virella. (2000). Oxidized LDL induces the expression of ALBP/aP2 mRNA and protein in human THP-1 macrophages. Journal of Lipid Research. 41(12). 2017–2023. 121 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact